Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
  • 首页
(End)The 8th Asia Pharma R&D Leaders 2018

The 8th Asia Pharma R&D Leaders 2018

Time: Jan.24th-25th,2018

Adress:Grand Mercure Beijing Dongcheng(NO.101,Jiaodaokou East Street Dongcheng District, Beijing

The 8th Asia Pharma R&D Leaders 2018

Conference Overview

The 8th Asia Pharma R&D Leaders 2018 is designed to be a premium strategic platform for big pharmas, biotechs, academia and other stake holders in pharma industry to meet, communicate and establish partnership on pharma R&D. Leading executives will discuss key topics of global R&D trends, development strategies, innovation capability building and collaboration opportunities. It is an efficient exchange platform for global pharmaceutical leaders to optimize R&D strategic innovation, grasp cutting-edge R&D trend, intensify scientific R&D process management and deepen openness to external cooperation; to enhance the Asian pharmaceutical R&D innovation; to go for first in class in the world!

By keynote speech, roundtable discussion, company showcase, exhibition booth and 1-2-1 meeting system, this two-day event will share insightful ideas from Asian pharmaceutical leaders, as well as provide fat chances for you to find potential projects and partners. 

The 8th Asia Pharma R&D Leaders 2018

The 8th Asia Pharma R&D Leaders 2018

Event Organizer

The 8th Asia Pharma R&D Leaders 2018

Shine Consultant (Formerly the Shine Media) is a progressive business media, serving clients from around the world. We offer a comprehensive product mix, ranging from summits, business to business conferences, and trade shows to made-on-demand specialty seminars. By bringing business communities together, in person, in print or online, we help decision-makers to get ahead of the curve on emerging issues, make key connections, and reach out to new customers. As for financial industry, by far we have presented the following events series with influential partners: 9 of Payment China Summit, 2 of Asia Family Wealth Management,9 of Private Banking Asia, 3 of Asia Trade Finance Summit, 3 of Global Asset Management China, etc. 

(End)The 8th Asia Pharma R&D Leaders 2018
Conference Organizer / Co-Organizer
Guidance / co-sponsor / support
  • 新药创始人俱乐部
  • 台湾生物产业发展协会
  • CBA 美国华人生物医药科技协会
  • SAPA 美中药协
  • Ting Xu CEO Alphamab(Jiangsu)Biophamaceuticals Co.,Ltd
  • Shoubai Chao Prior to joining Medimmune, Dr. Chao served as ass...
  • Maggie Chang Vice President Hangzhou Tigermed Consulting Co., Ltd
  • Jonathan Ma PhD dMed
  • Zheng WANG Chairman of Scientific Advisory Board MITRO Biotech. Co., Ltd.
  • Danyi Wen President & CEO Shanghai LIDE Biotech
  • Yu Zhang CEO VCANBIO
  • Li Wei Director of Investment Consulting Service Center CMC
  • Yin Li Chief Business Officer Proswell
  • Li Xia Associate Partner IBM
  • John Winebarger CEO IDA
  • Lili Sui General Manager Shanghai  Sinobioway  SunTerra Biotechno...
  • CHENG Zengjiang President/Secretary General PharmaSea (Beijing) Biomedical Technology Co., Ltd...
  • ZHENG Weiyi President Innov Pharma
  • LI Gongshu Senior Vice President Fountain Medical (TIANJIN) Co., Ltd.
  • Angela YAN Senior Director - Science & Regulatory RDPAC
  • Helen MAO Senior Vice President / Board of Director CanSino Biologics Inc./ CBA -The Chinese Biop...
  • JOHN WINEBARGER CEO Japanese pharmaceutical companies
  • LIU Junjian VP, Biologics Discovery Innovent biologics
  • Lily Shen Director Morningside
  • HE Ting CEO ImmunoChina Pharmaceuticals Co. Ltd
  • Cindy RU Managing Director CRC Oncology Corp
  • ZHU Zhenping President of R&D, CSO 3SBio Inc.
  • Yuanwei Chen CEO and Founder Hinova Pharmaceuticals Inc.
  • Jimmy Zhang Transaction at Johnson & Johnson Innovation Johnson & Johnson
  • LI Shengfeng General Manager Bio-Thera Solutions, Ltd
  • JI Qunsheng Head of Oncology and Immunology Unit Wuxi apptec
  • Maggie Chang Vice President Drug Regulatory Policy
  • YE Bin Vice President Beijing Shenogen Biotech
  • Maggie Chang Vice President Drug Regulatory Policy
  • YE Bin Vice President Beijing Shenogen Biotech
  • Howard LIANG CFO and Chief Strategy Officer BeiGene
  • PENG Bin Global Head of TCO Shanghai Novartis
  • LI Zhengqing Global VP and General Manager MSD R&D(China)Co.,Ltd
  • Michelle XIA Chairman & CEO Akeso Biopharma Inc.
  • HUANG Yue Head of Early Development China Merck Serono
  • ZHAO Nanding Head of External Innovation China Novartis Institutes for BioMedical Research ...
  • Lili Sui General Manager Shanghai HRAIN Biotechnology Co.,Ltd
  • John Niu CEO/会长 President McCull Pharmaceutical /  SUBIA-Sino...

The 8th Asia Pharma R&D Leaders 2018

  • univ
  • Proswell
  • LIDE
  • Career International
  • West
  • China Medical City
  • AnJie Law Firm
  • dMed
  • Komtur
  • Irvine Scientific
  • Almac Profile
  • Hangzhou Tigermed Consulting Co., Ltd
  • MITRO Biotec
  • Biocair
  • Integrated Development Associates Co., Ltd. (IDA)
  • Clinical Service Center
Cooperative Media
Travel & Stay

More contact information


TEL:+86 21-52428082